Accelerating Pediatric Drug Development

This forum will assess the feasibility and potential design of mechanism-of-action based Phase I/II master trial platforms for concurrently studying multiple molecules across a range of relevant pediatric tumor types and discuss methods to rationally select the most promising molecules to take forward from a master trial into pivotal studies.